Har­vard prof Omid Farokhzad heads west, set­ting up a new Bay Area biotech on a mis­sion to start a rev­o­lu­tion in pre-symp­to­matic dis­ease de­tec­tion

As a Har­vard pro­fes­sor with close ties to MIT’s Bob Langer, Omid Farokhzad has en­joyed a high-pro­file role in the Boston/Cam­bridge biotech com­mu­ni­ty, where he’s par­tic­i­pat­ed in launch­ing a line­up of star­tups. And now Farokhzad — whose ac­com­plish­ments ex­tend to his role as physi­cian-sci­en­tist at Brigham and Women’s Hos­pi­tal — has put it all in his rear view mir­ror, jour­ney­ing out to the Bay Area to launch a new biotech he vows can go on to play a rev­o­lu­tion­ary role in open­ing the door to the ear­ly de­tec­tion of dis­eases.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER